New Ultrasound-Guided injection technique tested for back pain relief
NCT ID NCT06572579
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot study tested whether using ultrasound to guide pharmacopuncture (herbal injections) is safe and effective for neck and back pain. Fifty adults with spinal disorders received the treatment, and researchers tracked side effects, pain levels, disability, and quality of life. The goal was to see if this approach could improve precision and outcomes for common spinal pain.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- pharmacopuncture (herbal medicine injected into acupuncture points)
- What this could lead to
- If results are positive, this could point toward a safer, more precise way to treat spinal pain using ultrasound guidance.
- What could go wrong
- This is a small pilot study with only 50 participants and no comparison group, so results may not be generalizable. The treatment may not prove effective in larger trials.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
50 people
The number who actually took part.
- Started
-
Sep 2024
- Finished
-
Feb 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients diagnosed with spinal disorders who have undergone ultrasound-guided pharmacopuncture treatment
- Ages
-
19 to 70 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Individuals diagnosed with spinal disorders (M code and S code based on KCD criteria) 2. Outpatients scheduled for ultrasound-guided pharmacopuncture treatment 3. Individuals aged 19 years or older and under 70 years 4. Individuals who agree to participate in the clinical study and voluntarily sign the consent form Exclusion Criteria: 1. Individuals who are unable to complete the consent form 2. Individuals who are deemed unsuitable for participation in the clinical study by the researcher
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Back pain are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Bucheon Jaseng Hospital of Korean Medicine
Bucheon-si, Gyeonggi Province, 14598, South Korea
-
Daejeon Jaseng Hospital of Korean medicine
Daejeon, Seo-gu, South Korea
-
Jaseng Hospital of Korean medicine
Seoul, Gangnam-Gu, 135-896, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can yoga ease back pain when recovery looks unlikely?
- Can a 13-Minute eye exercise routine ease screen strain?
- Can a Screen-Guided neck workout retrain muscles to ease chronic pain?
- Can a Longer-Lasting nerve block cut opioid use after spine surgery?
- Which neck therapy works better? a Head-to-Head test
- Can diaphragm exercises ease stubborn neck pain?